"It was very disappointing and one of those days where our decision making wasn't great," said Boro's boss. "We've never been as bad as that but it happens, it shouldn't define us and we're now ...
“We are excited to provide an updated assessment of objective response to dordaviprone previously reported in the blinded independent central review (BICR) cohort 1 in recurrent H3 K27M-mutant diffuse ...